Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy

https://doi.org/10.1016/S0002-9149(02)03404-5Get rights and content

Abstract

Biventricular pacing results in left ventricular (LV) reverse remodeling in heart failure patients with wide QRS complexes. This study examines potential predictors of reverse remodeling. Echocardiography with tissue Doppler imaging was performed at baseline and 3 months after biventricular pacing in 30 patients (21 men and 9 women, mean age 62 ± 14 years). There were 17 responders to reverse remodeling (defined as a reduction in LV end-systolic volume by >15%) and 13 nonresponders. Responders had significant improvement in 6-minute hall-walking distance (p = 0.006), metabolic equivalents (p = 0.02), peak oxygen uptake (p = 0.02), New York Heart Association functional class (p <0.001), and quality of life (p <0.001); an increase in the sphericity index (p = 0.007), ejection fraction (p <0.001), and diastolic filling time (p = 0.03); a decrease in myocardial performance index (p = 0.02), isovolumic relaxation time (p = 0.004), and mitral regurgitation (p = 0.007); and an improvement in systolic dyssynchrony (SD of the time to peak myocardial systolic contraction of the 12 LV segments as dyssynchrony index) (45.0 ± 8.3 vs 32.5 ± 14.5 ms, p = 0.003). In contrast, nonresponders only had a small degree of clinical improvement in New York Heart Association class (p = 0.03) and quality-of-life scores (p = 0.03), without any change in cardiac function, and worsening of systolic dyssynchrony (24.8 ± 4.5 vs 34.1 ± 13.5 ms, p = 0.02). When all the above factors were put into univariate and multivariate analyses models, systolic dyssynchrony was the only independent predictor of reverse remodeling (r = −0.76, p <0.001) (β = −1.54, p = 0.007). A preimplant dyssynchrony index of 32.6 ms (+2 SDs from mean of 88 normal controls) was able to totally segregate responders from nonresponders of biventricular pacing. Thus, responders of LV reverse remodeling were associated with improvement in clinical status, cardiac function, and systolic synchronicity. Direct assessment of systolic synchronicity by tissue Doppler imaging is highly accurate in predicting responders to therapy.

Section snippets

Patients

Thirty patients (21 men and 9 women, mean age 62 ± 14 years) in New York Heart Association (NYHA) class III (n = 18) or IV (n = 12) heart failure, LV ejection fraction <40%, and prolonged QRS of >140 ms, received biventricular pacing therapy. Among these patients, 17 (57%) had left bundle branch block, and 13 (43%) had intraventricular conductional delay. The PR interval was >200 ms in 15 patients (50%). The etiologies of heart failure were ischemic in 12 and nonischemic in 18 patients.

Results

Biventricular pacemakers were successfully implanted in all patients. At 3-month follow-up, biventricular pacing was maintained in all patients. The QRS duration decreased from 167 ± 33 to 145 ± 25 ms (p = 0.001). No patients were pacing dependent.

Lv reverse remodeling: new insight into responders and nonresponders

LV remodeling is a major phenotypic component of the pathophysiologic mechanisms of heart failure.15 Recently, LV reverse remodeling was demonstrated after biventricular pacing therapy,1, 5, 11, 16, 17 apart from symptomatic benefits.1, 18, 19, 20 Nonetheless, nonresponders of biventricular pacing were observed at long-term follow-up, and could be classified as hemodynamic, clinical, or volumetric nonresponders.21 In the only study that addressed nonresponders to LV reverse remodeling using LV

References (23)

  • J.C. Daubert et al.

    Permanent left ventricular pacing with transvenous leads inserted into the coronary veins

    Pacing Clin Electrophysiol

    (1998)
  • Cited by (633)

    • Imaging biomarkers for cardiovascular diseases

      2019, Handbook of Medical Image Computing and Computer Assisted Intervention
    • The saga of dyssynchrony imaging: Are we getting to the point

      2023, Frontiers in Cardiovascular Medicine
    View all citing articles on Scopus
    View full text